Progress in probiotics for treating Clostridioides difficile infection / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
;
(12): 652-658, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-958239
ABSTRACT
Clostridioides difficile infection (CDI) is an infectious disease with fever, abdominal pain and diarrhea as the main clinical manifestations. At present, CDI is mainly treated with antibiotics and faecal microbiota transplantation. As recurrent and refractory CDI continues to increase, it is important to seek a more effective alternative therapy. However, many of the studies on the prevention and control of CDI by probiotics are still in the early stage. This paper summarized the research on the types, mechanisms and technical means of probiotics in the treatment of CDI.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Microbiology and Immunology
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS